Outcome Evaluation After Fertility Preservation
1 other identifier
observational
100
1 country
1
Brief Summary
It is important to evaluate outcomes after different fertility preservation strategies. Therefore, this study aims to assess the outcomes after different fertility preservation strategies and identify any factors that may affect their reproductive outcome.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Sep 2023
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 12, 2023
CompletedFirst Posted
Study publicly available on registry
September 21, 2023
CompletedStudy Start
First participant enrolled
September 21, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2033
ExpectedStudy Completion
Last participant's last visit for all outcomes
October 1, 2035
January 8, 2026
January 1, 2026
10 years
September 12, 2023
January 6, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
To determine any factors that may affect the success rate of different fertility preservation methods.
The medical notes of these patients undergoing fertility preservation services will be reviewed. The baseline characteristics including the socio-demographic background will be obtained by reviewing their hospital record.
10 years
Secondary Outcomes (2)
To assess the pregnancy rate after different fertility preservation methods.
10 years
To report on the frequency of surgical complications
10 years
Interventions
This is an observational cohort study
Eligibility Criteria
All patients who have undergone or will seek for fertility preservation services in PWH will be invited to participate.
You may qualify if:
- Patients aged from 0-50 years old
- Patients with any illness or who will undergo any type of treatment that may cause irreversible damage to their fertility, such as extensive abdominal surgery, high toxicity medication and treatments;
- Patients seek for fertility preservation services
You may not qualify if:
- Patients unable to provide consent/assent (i.e. significant psychiatric problems/cognitive delay)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Prince of Wales Hospital
Hong Kong, Hong Kong
Biospecimen
When patients come back after the use of frozen gametes, embryos or tissue, discarded or residual cryopreserved gamete, embryos or tissue will be used for histological and pathological assessment to determine its quality. Donated samples cannot be retrieved/ used for future fertility treatment.
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jacqueline CHUNG, MBBS
Chinese University of Hong Kong
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
September 12, 2023
First Posted
September 21, 2023
Study Start
September 21, 2023
Primary Completion (Estimated)
October 1, 2033
Study Completion (Estimated)
October 1, 2035
Last Updated
January 8, 2026
Record last verified: 2026-01
Data Sharing
- IPD Sharing
- Will not share